Asia / HONG KONG
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
Jiangxi Institute of Biological Products, Inc. is engaged in the research, production and sales of antitoxin and immune serum biological products. The company is mainly engaged in biological products such as tetanus antitoxin, blood stimulating hormone for injection, and chemical products such as chlorine dioxide, povidone iodine, and enhanced glutaraldehyde. The company was founded in 1969 and is headquartered in Ji'an, China.
Jiangxi Institute of Biological Products, Inc. is engaged in the research, production and sales of antitoxin and immune serum biological products. The company is mainly engaged in biological products such as tetanus antitoxin, blood stimulating hormone for injection, and chemical products such as chlorine dioxide, povidone iodine, and enhanced glutaraldehyde. The company was founded in 1969 and is headquartered in Ji'an, China.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Biological Products Exc. Diagnostic |
| Country | HONG KONG |
| Employees | 327 |
| Reporting Unit | Millions |
| Primary Exchange | HKG |
| Instrument Type | Equity |
| Wright ID | C344P3QF5 |
Key Metrics
| Current price | $5.85 |
| Market cap | $1.80 B |
| P/E ratio | n/a |
| Common shares | 308.4 M |
| Share type | H Gu |
| Quality rating | DAD0 |
| Dividend yield | n/a |
Recent stock performance
| 1 Week | -1.0% |
| 4 Week | -48.2% |
| 13 Week | -61.7% |
Officers
n/a
Address
HONG KONG
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.